The importance of epigenetic factors for the diagnostics and treatment of type 2 diabetes mellitus

被引:1
|
作者
Stelmaszyk, Agnieszka [1 ]
Dworacka, Marzena [1 ]
机构
[1] Poznan Univ Med Sci, Dept Pharmacol, Poznan, Poland
来源
CLINICAL DIABETOLOGY | 2018年 / 7卷 / 03期
关键词
epigenetics; type 2 diabetes mellitus; metabolic memory; intergenerational transmission;
D O I
10.5603/DK.2018.0013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The level of expression of certain genes modifying the phenotype may affect the progression of diabetes mellitus and its complications. Gene expression is controlled by epigenetic modifications, influenced by intracellular and environmental factors, e.g. nutrition model and physical activity. These modifications appear throughout whole life, from conception until the time of death, and they are closely dependent on cell differentiation, DNA repair and cellular stress. Hopefully, the knowledge of epigenetics might be used in the future as an element of personalized treatment of diabetes. The following article aims to review the most important mechanisms of epigenetic modifications in context of pathogenesis and pathophysiology of type 2 diabetes mellitus.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [21] Importance of Dyslipidaemia Treatment in Individuals with Type 2 Diabetes Mellitus-A Narrative Review
    Strikic, Dominik
    Vujevic, Andro
    Perica, Drazen
    Leskovar, Dunja
    Paponja, Kristina
    Pecin, Ivan
    Mercep, Iveta
    DIABETOLOGY, 2023, 4 (04): : 538 - 552
  • [22] Diabetes mellitus type 2 and risk factors
    Milovancevic, S.
    Vukotic, J.
    Bunjak, L.
    Grujic, B.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 170S - 170S
  • [23] Risk factors for type 2 diabetes mellitus
    Vázquez, JA
    Gaztambide, S
    Soto-Pedre, E
    MEDICINA CLINICA, 2001, 116 (10): : 399 - 399
  • [24] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [25] Factors associated with type 2 diabetes mellitus treatment choice across Europe
    Heintjes, E. M.
    Overbeek, J. A.
    Hall, G. C.
    Lapi, F.
    Prieto-Alhambra, D.
    Bezemer, I. D.
    DIABETOLOGIA, 2015, 58 : S405 - S405
  • [26] Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    Baak-Pablo, Renee F.
    Assendelft, Willem J. J.
    Wessels, Judith A. M.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (08): : 461 - 468
  • [27] Diabetes: Genetic risk factors in type 2 diabetes mellitus
    Richards L.
    Nature Reviews Endocrinology, 2009, 5 (8) : 414 - 414
  • [28] Epigenetic Mechanisms in Type-2 Diabetes Mellitus: A Narrative Review
    Ashok, Deenadhayalan
    Prasad, Monisha
    Fareed, Mohammad
    Chaudhary, ANiS A. H. M. A. D.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2025, 19 (01) : BE7 - BE11
  • [29] Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and epigenetic Links
    De Rosa, Salvatore
    Arcidiacono, Biagio
    Chiefari, Eusebio
    Brunetti, Antonio
    Indolfi, Ciro
    Foti, Daniela P.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [30] Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
    Liu, Jiangman
    Lang, Guangping
    Shi, Jingshan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 431 - 442